Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors

Annals of Anatomy

Volumn 195, Issue 5, 2013, Pages 461-466

  Anitua, Eduardo ^a,b   Zalduendo, Mari Mar ^b   Alkhraisat, Mohammad Hamdan ^b   Orive, Gorka ^b  

^a Biotechnology Institute (BTI)   (Spain)

^b Biotechnology Institute BTI   (Spain)

Author keywords

Growth factors; Inflammation; Leukocytes; Platelet rich plasma; Regenerative medicine

Indexed keywords

FIBRIN; INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; SCAFFOLD PROTEIN; SCATTER FACTOR; SOMATOMEDIN; VASCULOTROPIN;

ARTICLE; BLOOD AUTOTRANSFUSION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; FIBRIN CLOT; IN VITRO STUDY; INCUBATION TIME; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STEADY STATE; THROMBOCYTE FREE PLASMA; THROMBOCYTE RICH PLASMA;

GROWTH FACTORS; INFLAMMATION; LEUKOCYTES; PLATELET RICH PLASMA; REGENERATIVE MEDICINE;

ALGORITHMS; BLOOD PLATELETS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1BETA; KINETICS; MICROSCOPY, ELECTRON, SCANNING; PLASMA; PLATELET-DERIVED GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84887131542     PISSN: 09409602     EISSN: 16180402     Source Type: Journal    
DOI: 10.1016/j.aanat.2013.04.004     Document Type: Article

References (29)

1. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int. J. Oral Maxillofac. Implants 1999, 14:529-535.
2. Anitua E., Alkhraisat M.H., Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J. Control. Release 2012, 157:29-38.
3. Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb. Haemost. 2004, 91:4-15.
4. Anitua E., Sanchez M., Orive G., Andia I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007, 28:4551-4560.
5. Anitua E., Tejero R., Alkhraisat M., Orive G. Platelet-rich plasma to improve the bio-functionality of biomaterials. BioDrugs 2013, 27:97-111.
6. Anitua E., Troya M., Orive G. Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-beta1-induced myodifferentiation. J. Periodontol. 2012, 83:1028-1037.
7. Bessho K., Kusumoto K., Fujimura K., Konishi Y., Ogawa Y., Tani Y., Iizuka T. Comparison of recombinant and purified human bone morphogenetic protein. Br. J. Oral Maxillofac. Surg. 1999, 37:2-5.
8. Bielecki T., Cieslik-Bielecka A., Żelawski M., Mikusek W. A side-effect induced by the combination of a demineralized freeze-dried bone allograft and leucocyte and platelet-rich plasma during treatment for large bone cysts: a 4-year follow-up clinical study. Transfus. Apher. Sci. 2012, 47:133-138.
9. Campbell P.G., Durham S.K., Hayes J.D., Suwanichkul A., Powell D.R. Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin. J. Biol. Chem. 1999, 274:30215-30221.
10. Castillo T.N., Pouliot M.A., Kim H.J., Dragoo J.L. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am. J. Sports Med. 2011, 39:266-271.
11. Curi M.M., Cossolin G.S., Koga D.H., Araujo S.R., Feher O., dos Santos M.O., Zardetto C. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases. J. Oral Maxillofac. Surg. 2007, 65:349-355.
12. Del Fabbro M., Bortolin M., Taschieri S., Weinstein R. Is platelet concentrate advantageous for the surgical treatment of periodontal diseases? A systematic review and meta-analysis. J. Periodontol. 2011, 82:1100-1111.
13. Drinnan C.T., Zhang G., Alexander M.A., Pulido A.S., Suggs L.J. Multimodal release of transforming growth factor-beta1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels. J. Control. Release 2010, 147:180-186.
14. Filardo G., Kon E., Pereira Ruiz M., Vaccaro F., Guitaldi R., Di Martino A., Cenacchi A., Fornasari P., Marcacci M. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single-versus double-spinning approach. Knee Surg. Sports Traumatol. Arthrosc. 2012, 20:2082-2091.
15. Hock J.M., Canalis E. Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts. Endocrinology 1994, 134:1423-1428.
16. James R., Bradshaw R.A. Polypeptide growth factors. Annu. Rev. Biochem. 1984, 53:259-292.
17. Kakudo N., Minakata T., Mitsui T., Kushida S., Notodihardjo F.Z., Kusumoto K. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast. Reconstr. Surg. 2008, 122:1352-1360.
18. Martin P. Wound healing-aiming for perfect skin regeneration. Science 1997, 276:75-81. (New York, N.Y.).
19. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., Georgeff K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1998, 85:638-646.
20. McCarrel T.M., Minas T., Fortier L.A. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J. Bone Joint Surg. 2012, 94(e143):141-148.
21. Meinel L., Zoidis E., Zapf J., Hassa P., Hottiger M.O., Auer J.A., Schneider R., Gander B., Luginbuehl V., Bettschart-Wolfisberger R., Illi O.E., Merkle H.P., von Rechenberg B. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 2003, 33:660-672.
22. Mozzati M., Gallesio G., Arata V., Pol R., Scoletta M. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol. 2012, 48:469-474.
23. Rai B., Teoh S.H., Ho K.H. An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma. J. Control. Release 2005, 107:330-342.
24. Rosano G., Taschieri S., Del Fabbro M. Immediate post-extraction implant placement using PRGF technology in maxillary premolar region: a new strategy for soft tissue management. J. Oral Implantol. 2013, 39:98-102.
25. Sahni A., Francis C.W. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000, 96:3772-3778.
26. Sakiyama-Elbert S.E., Das R., Gelberman R.H., Harwood F., Amiel D., Thomopoulos S. Controlled-release kinetics and biologic activity of platelet-derived growth factor-BB for use in flexor tendon repair. J. Hand Surg. 2008, 33:1548-1557.
27. Weibrich G., Hansen T., Kleis W., Buch R., Hitzler W.E. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 2004, 34:665-671.
28. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83:835-870.
29. Wirz S., Dietrich M., Flanagan T.C., Bokermann G., Wagner W., Schmitz-Rode T., Jockenhoevel S. Influence of platelet-derived growth factor-AB on tissue development in autologous platelet-rich plasma gels. Tissue Eng. 2011, 17:1891-1899.